Prolonged remission of metastatic malignant fibrous histiocytoma induced by combination chemotherapy
- 1 June 1984
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 26 (2) , 113-114
- https://doi.org/10.1002/jso.2930260208
Abstract
A patient with metastatic malignant fibrous histiocytoma (MFH) achieved a complete remission with polychemotherapy lasting 42+ months. In view of this long‐term survival and two similar prior reports of long‐term survival after aggressive treatment, the goal of therapy for metastatic MFH must be reconsidered.Keywords
This publication has 7 references indexed in Scilit:
- High‐dose cyclophosphamide and adriamycin with DTIC maintenance for metastatic soft tissue sarcomasJournal of Surgical Oncology, 1983
- Malignant fibrous histiocytomaThe American Journal of Surgical Pathology, 1982
- Combination chemotherapy (CYVADIC) in metastatic soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1982
- Malignant fibrous histiocytoma a retrospective study of 167 casesCancer, 1980
- Chemotherapy of malignant fibrous histiocytoma.A southwest oncology group reportCancer, 1977
- Inflammatory fibrous histiocytoma—An aggressive and lethal lesionCancer, 1976
- Chemotherapy of sarcomasCancer, 1975